Pretomanid for tuberculosis: a systematic review
Authors:
Open Access
- 1 January 2022
- journal article
- review article
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 28 (1) , 31-42
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Phase II Dose-Ranging Trial of the Early Bactericidal Activity of PA-824Antimicrobial Agents and Chemotherapy, 2012
- Sterilizing Activity of Novel TMC207- and PA-824-Containing Regimens in a Murine Model of TuberculosisAntimicrobial Agents and Chemotherapy, 2011
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Early Bactericidal Activity and Pharmacokinetics of PA-824 in Smear-Positive Tuberculosis PatientsAntimicrobial Agents and Chemotherapy, 2010
- Assessment of the Effects of the Nitroimidazo-Oxazine PA-824 on Renal Function in Healthy SubjectsAntimicrobial Agents and Chemotherapy, 2009
- Safety, Tolerability, and Pharmacokinetics of PA-824 in Healthy SubjectsAntimicrobial Agents and Chemotherapy, 2009
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLOS Medicine, 2009
- The mechanism of action of PA-824Communicative & Integrative Biology, 2009
- PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO ReleaseScience, 2008
- Bactericidal Activity of the Nitroimidazopyran PA-824 in a Murine Model of TuberculosisAntimicrobial Agents and Chemotherapy, 2005